Overview of age-variations
Age group comparisons |
PMID |
Age/Age interval, Gender |
Value (unit of measurement) |
Method |
Sample |
18384253 |
Age 24.5 ± 3, Gender ⚥ |
0.9 (mean value of the compound area) |
LC-MS; GC-MS |
plasma |
18384253 |
Age 40.8 ± 5.6, Gender ⚥ |
0.83 (mean value of the compound area) |
LC-MS; GC-MS |
plasma |
18384253 |
Age 55.6 ± 3.7, Gender ⚥ |
0.77 (mean value of the compound area) |
LC-MS; GC-MS |
plasma |
27374292 |
Age [25–35] (median=32), Gender ♀ (Japanese) |
0.693227 (average level of metabolite) |
UHPLC-MS/MS Positive mode |
serum |
27374292 |
Age [55–65] (median=60), Gender ♀ (Japanese) |
0.988538 (average level of metabolite) |
UHPLC-MS/MS Positive mode |
serum |
27374292 |
Age [25–35] (median=32), Gender ♂ (Japanese) |
0.918931 (average level of metabolite) |
UHPLC-MS/MS Positive mode |
serum |
27374292 |
Age [55–64] (median=60), Gender ♂ (Japanese) |
1.37054 (average level of metabolite) |
UHPLC-MS/MS Positive mode |
serum |
Linear regression |
PMID |
Age/Age interval, Gender |
Value (unit of measurement) |
Method |
Sample |
log2 ratio/log2(FC) |
PMID |
Age/Age interval, Gender |
Value (unit of measurement) |
Method |
Sample |